All posts tagged "Pharmaceuticals"
-
61Stocks NewsOmnicell Stock Analysis: Key Factors for Investors
March 24, 2026 — Omnicell, Inc. (NASDAQ: OMCL), a provider of medication management solutions for healthcare systems, presents investors with a mix...
-
65Stocks News
Ovid Therapeutics Q4 Earnings Beat Estimates
Ovid Therapeutics Inc. (NASDAQ: OVID) reported fourth-quarter financial results that exceeded analyst expectations, marking a significant shift to profitability. The biotechnology company...
-
90Business News
Two Major Drug Firms Join TrumpRx Initiative
Two of the nation’s largest pharmaceutical manufacturers have formally joined the TrumpRx prescription drug pricing program, according to official announcements from the...
-
94Stocks News
Coherus Oncology Q4 Loss Widens: CHRS Stock Analysis and 2026 Outlook
REDWOOD CITY, Calif. — March 9, 2026: Biotechnology firm Coherus BioSciences, Inc. (NASDAQ: CHRS) reported a wider-than-expected fourth-quarter loss after markets closed...
-
81Stocks News
Breaking: ESPR Stock Dives 11% After Mixed Q4 Earnings Report
March 11, 2026 — ANN ARBOR, Mich. — Shares of Esperion Therapeutics (NASDAQ: ESPR) plummeted approximately 11% in Tuesday’s trading session following...
-
93Stocks News
Breaking: Can Novo Nordisk’s Hims & Hers Deal Revive Its Critical GLP-1 Momentum?
PLAINSBORO, New Jersey & SAN FRANCISCO, California — March 11, 2026: In a strategic pivot that stunned market observers, Danish pharmaceutical giant...
-
99Stocks News
Breaking: Xenon Pharmaceuticals Stock Surges Past $56.39 Analyst Target Price
VANCOUVER, British Columbia — March 10, 2026: In a significant market development, shares of Xenon Pharmaceuticals Inc (NASDAQ: XENE) surged past the...
-
105Stocks News
ADC Therapeutics Beats Q4 Estimates with 55% Earnings Surprise
LAUSANNE, Switzerland — March 3, 2022: ADC Therapeutics SA (NYSE: ADCT) reported fourth-quarter 2021 financial results this morning, revealing a narrower-than-expected loss...
-
103Stocks News
Opus Genetics Q4 Earnings: Loss Widens But Revenue Beats by 47%
RALEIGH, N.C. — March 10, 2026: Opus Genetics, Inc. (NASDAQ: IRD) reported mixed fourth-quarter results this morning that revealed a widening loss...
-
99Stocks News
Breaking: ARS Pharmaceuticals (SPRY) Posts Q4 Loss But Delivers Critical Revenue Beat
San Diego, California — March 9, 2026: ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) reported mixed fourth-quarter results this morning, posting a loss that...
